Article Text

Download PDFPDF
Photodynamic therapy in non-subfoveal choroidal neovascularization secondary to pathological myopia: 1-year outcome
  1. Juan Reche-Frutos,
  2. Cristina Calvo-González,
  3. Juan Donate-López,
  4. Julián García-Feijoó,
  5. M Wasfy,
  6. F Saenz-Frances,
  7. C Fernandez-Perez,
  8. J Garcia-Sanchez
  1. Hospital Universitario Clínico San Carlos, Madrid, Spain
  1. Juan Reche-Frutos, Calle profesor martín lagos s/n 28040 Madrid, Spain; rechejuan{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

This prospective, open-label, non-comparative, interventional case series evaluates the results of photodynamic therapy (PDT) in juxtafoveal and extrafoveal choroidal neovascularization (CNV) secondary to pathologic myopia in 27 eyes of 27 patients.

The average visual acuity dropped from 58.5 letters to 49.19. The visual acuity remained stable in 13 patients (48.1%), whereas 14 patients (51.9%) lost more than 8 letters due to the extension of the lesion to subfoveal space. A strong association was found between advanced age and a worse visual prognosis (p = 0.001).

PDT may stabilise visual acuity in young patients with non-subfoveal CNV secondary to pathologic myopia.

The long-term visual prognosis of myopic CNV is …

View Full Text


  • Competing interests: None declared